Range
1.39 - 1.47
Vol / Avg.
181.2K/294.9K
Div / Yield
-
52 Wk
1.33 - 3.24
Mkt Cap
84.7M
Payout Ratio
-
Open
1.42
P/E
-
EPS
-0.09
Shares
59.7M
Outstanding
59.7M
Total Float
34.6M
load more
Sector: Health Care.Industry: Biotechnology
Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204, P205, and P103.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.120-0.120 0.0000
REV190.000K375.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LPTXLeap Therapeutics-0.7%84.7M

Leap Therapeutics Frequently Asked Questions

Q

How do I buy Leap Therapeutics (LPTX) stock?

A

You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Leap Therapeutics's (LPTX) competitors?

Q

What is the target price for Leap Therapeutics (LPTX) stock?

A

The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Raymond James on March 2, 2021. The analyst firm set a price target for 3.50 expecting LPTX to rise to within 12 months (a possible 146.48% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Leap Therapeutics (LPTX)?

A

The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.42 last updated Fri Jul 30 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Leap Therapeutics (LPTX) pay a dividend?

A

There are no upcoming dividends for Leap Therapeutics.

Q

When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?

A
Leap Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Leap Therapeutics (LPTX) going to split?

A

There is no upcoming split for Leap Therapeutics.

Q

What sector and industry does Leap Therapeutics (LPTX) operate in?

A

Leap Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.